[ACCESSWIRE]
LAS VEGAS, NV / ACCESSWIRE / October 17, 2017 / Praxsyn Corporation's (OTC PINK: PXYN) wholly-owned subsidiary pharmacy, Nevada Health Rx, Inc., d/b/a Prax-Rx ("Prax-Rx"), located in Las Vegas, Nevada, is pleased to announce that it has received notification that its non-resident pharmacy applications in Arizona and Georgia have been approved, it has paid off its promissory note for the acquisition of the pharmacy assets of Prax-Rx, and now, Prax-Rx has the capability, through its pharmacy services administration organization, to accept certain commercial insurances.
Greg Sundem, Praxsyn's Chief Executive Officer, commented, "In addition to securing a Nevada Pharmacy license, Prax-Rx has secured its non-resident pharmacy licenses in Georgia and Arizona. Prax-Rx is currently shipping to Georgia and plans to be shipping into Arizona in the very near future. Prax-Rx's strategy is to only secure out of state pharmacy licenses where real sales opportunities exist. The focus of Prax-Rx, as a specialty pharmacy, is to continue increasing the diversity of our product lines with a broad product mix, which will provide stability for the company into the future."
Praxsyn Corporation's financial reporting continues to be a priority and is expected to be completed shortly. Further updates will be released as necessary and the financial reporting will be posted as expeditiously as possible.
About Praxsyn Corporation
Headquartered in Las Vegas, Nevada, Praxsyn Corporation through its wholly owned subsidiaries Mesa Pharmacy and Prax-Rx, work to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding the progress of Prax-Rx, and thus accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.
Media/Investor Contact:
[email protected]
949-777-6112 ext. 101
SOURCE: Praxsyn Corporation
